Evaluation of Anxiety Reduction in the Cathlab by Means of Pharmacological and Non-pharmacological Strategies

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOlivier F. Bertrand

About this trial

The goal of this prospective pilot study is to learn if the use of virtual reality and/or relaxing soundscapes can help lower anxiety in adult patients undergoing a scheduled coronary angiography or angioplasty as compared to the standard of care. The main questions it aims to answer are:

* The use of non-pharmacological strategies reduces intraprocedural stress and anxiety compared to standard of care * Reducing anxiety limits the use of pharmacological agents, which increases patient safety.

Researchers will compare the use of relaxing soundscapes or virtual reality to the standard of care to see the effects of these strategies on pain, anxiety and stress.

Participants will:

* listen to relaxing soundscapes, OR experience virtual reality including soundscapes OR standard of care during their procedure, * Answer pain, anxiety and recovery questionnaires, * Answer satisfaction questionnaires.

Eligibility criteria

Qualifiers

Adults, 18 years or older

Scheduled hemodynamic intervention (coronary angiography and/or angioplasty)

Patient willing and able to understand the study

Signed informed consent

Disqualifiers

Scheduled complex procedure (CTO, structural)

Severe cognitive or psychiatric disorders

Major hearing/visual impairment

Severe motion sickness or history of malaise with Virtual Reality (VR)

Trial design

Treatments tested in this trial

  • Auditive experience
  • Audiovisual immersive experience

Treatment groups

60 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Olivier F. Bertrand

Lead sponsor

Laval University

Sponsor institution